Codes / ICD10CM / M1A.1520

M1A.1520 Lead-induced chronic gout, left hip, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Left Hip, Without Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to elevated uric acid levels and recurrent joint inflammation. This specific presentation affects the left hip and is characterized by the absence of tophi (urate crystal deposits), resulting in persistent symptoms and potential tissue damage if untreated.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term occupational or environmental lead exposure
  • History of gout or hyperuricemia
  • Male gender
  • Middle-aged or older adults

Symptoms

  • Recurrent episodes of intense joint pain in the left hip
  • Persistent swelling, redness, and warmth in the affected area
  • Stiffness and limited left hip mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and confirms the left hip as the affected site. The absence of tophi is noted during physical examination and imaging.

Treatment Options

  • Medications to reduce uric acid levels (e.g., allopurinol)
  • Anti-inflammatory drugs for pain and swelling
  • Chelation therapy to reduce lead levels
  • Lifestyle modifications to avoid lead exposure

Prognosis and Follow-Up

With proper treatment, symptoms can be managed, and joint damage may be minimized. Regular follow-up is necessary to monitor uric acid levels, lead exposure, and joint health. Untreated cases may lead to progressive joint damage and functional impairment.

Complications

  • Chronic joint damage or deformity
  • Persistent pain and reduced mobility
  • Increased risk of kidney stones or renal impairment
  • Potential for tophi development over time

Lifestyle & Prevention

  • Avoid lead exposure (e.g., occupational safety measures)
  • Maintain a balanced diet low in purines
  • Stay hydrated to support uric acid excretion
  • Limit alcohol consumption, which can trigger flare-ups

When to Seek Professional Help

Seek medical attention if experiencing severe or worsening left hip pain, swelling, or stiffness, or if symptoms interfere with daily activities. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

Document the absence of tophi clearly in clinical notes, as this distinguishes the condition from lead-induced chronic gout with tophi. Ensure the left hip is specified as the affected site. Verify that lead exposure is confirmed or strongly suspected, as this is a key diagnostic criterion.

Book a walkthrough

M1A.1520 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.